Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children
Open accessThe DOI matches its Crossref record; 244 of the 246 references it cites were found in a registry or an index.
Abstract
Background.: Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality worldwide, yet many questions related to its diagnosis remain. Methods.: A task force supported by the American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America searched, selected, and synthesized relevant evidence. The evidence was then used as the basis for recommendations about the diagnosis of tuberculosis disease and LTBI in adults and children. The recommendations were formulated, written, and graded using the Grading, Recommendations, Assessment, Development and Evaluation (GRADE) approach. Results.: Twenty-three evidence-based recommendations about diagnostic testing for latent tuberculosis infection, pulmonary tuberculosis, and extrapulmonary tuberculosis are provided. Six of the recommendations are strong, whereas the remaining 17 are conditional. Conclusions.: These guidelines are not intended to impose a standard of care. They provide the basis for rational decisions in the diagnosis of tuberculosis in the context of the existing evidence. No guidelines can take into account all of the often compelling unique individual clinical circumstances.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, culture may lead to misclassification of some cases of extrapulmonary tuberculosis as ‘not tuberculosis', owing to the paucibacillary nature of the disease.”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“This means that culture may have low sensitivity for extrapulmonary tuberculosis overall and further that culture sensitivity may differ for different forms of extrapulmonary tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“A recent evidence synthesis reported sensitivities of 72% to 88% in lymph node tissue, 28% to 81% in pleural fluid, 90% in pleural tissue, and 31% to 56% in CSF. Specificity ranged from 90% to 100% (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“For the 'Summary of findings' tables for CSF and pleural fluid, we provide evidence using culture as the reference standard, which is considered the best reference standard for tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 3×
“These assays are promising, but are not yet commercially available [146, 159, 160].”
BackgroundMethodGrading quality of evidence and strength of recommendations for diagnostic tests and strategies
Schünemann, H. J., Oxman, A. D., Brozek, J., Glasziou, P., Jaeschke, R., Vist, G. E., Williams, J. W., Kunz, R., Craig, J., Montori, V. M., et al. (2008) · BMJ · doi:10.1136/bmj.39500.677199.ae · Cited by 1,782
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732 · cited 1×
“The emergence of drug-resistant tuberculosis has become apparent over the past 2 decades, and in particular, multidrug-resistant tuberculosis (MDR-TB; resistant to isoniazid and rifampin) and extensively drug-resistant tuberculosis (XDR-TB; resistant to isoniazid and rifampin, plus any fluoroquinolone and at least 1 o…”
BackgroundSelwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & Friedland, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200901 · Cited by 1,574 · cited 1×
“For example, individuals who have a prior latent infection with Mtb (not treated) and then acquire HIV infection will develop TB disease at an approximate rate of 5%–10% per year (in the absence of effective HIV treatment) [18, 19].”
Background(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.16141 · Cited by 1,525
(2005) · PsycEXTRA Dataset · doi:10.1037/e545842006-001 · Cited by 1,274
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes
Woods, G. L., Brown‐Elliott, B. A., Conville, P. S., Desmond, E. P., Hall, G. S., Lin, G., Pfyffer, G. E., Ridderhof, J. C., Siddiqi, S. H., Wallace, R. J., et al. (2011) · Cited by 1,136
Self-citationMolecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C., & Stover, C. K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.5.1274-1282.1996 · Cited by 1,103
Research works printed but not linked: 8
- World Health Organization, 2015, Global tuberculosis report 2015
- T-SPOT.TB: an aid in the diagosis of tuberculosis infection; package insert for in vitro diagnositic use
- Perez, 2005, Impact of screening for latent TB before initiating anti-TNF therapy in North America and Europe, Ann Rheum Dis, 64, 265
- US Food and Drug Administration, 2008, Medical devices: T-SPOT-TB—P070006
- Forbes, 2008, Laboratory detection and identification of mycobacteria; approved guideline
- Francis J. Curry National Tuberculosis Center and California Department of Public Health, 2008, Drug-resistant tuberculosis: a survival guide for clinicians
- World Health Organization, 2008, Molecular line probe assays for rapid screening of patients at risk of multi-drug resistant tuberculosis (MDR-TB)
- Ena, 1990, The usefulness and limitations of adenosine deaminase in the diagnosis of tubercular pleurisy. A meta-analytical study [in Spanish], Med Clin (Barc), 95, 333
Cited by
Items 201–300 of 992
Treatment of Latent Tuberculosis Infection
Tang, P., & Johnston, J. C. (2017) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-017-0135-7 · Cited by 31
Rego, K., Pereira, K., MacDougall, J. E., & Cruikshank, W. W. (2017) · Tuberculosis · doi:10.1016/j.tube.2017.12.005 · Cited by 21
Pulmonary Alveolar Microlithiasis
Shaw, B. M., Shaw, S. D., & McCormack, F. X. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1702211 · Cited by 21
Shirzad‐Aski, H., Hamidi, N., Sohrabi, A., Abbasi, A., Golsha, R., & Movahedi, J. (2020) · Tropical Medicine & International Health · doi:10.1111/tmi.13452 · Cited by 26
“Therefore, based on the American Thoracic Society guideline, all patients with chronic and/or immunosuppressive diseases with a complicated condition should be screened for TB by a tuberculin skin test (TST) or IFN-c releasing assay (IGRA) [32].”
Marais, L. C., Nieuwoudt, L., Nansook, A., Menon, A., & Benito, N. (2023) · Journal of Bone and Joint Infection · doi:10.5194/jbji-8-189-2023 · Cited by 20
“The gold standard for diagnosis is currently considered to be the identification or isolation of M. tuberculosis by culture or NAAT, such as PCR (Hogan et al., 2017; Lewinsohn et al., 2017).”
Health status of Afro-Asian refugees in an Italian urban area: a cross-sectional monocentric study
Pinto, R. D., Pietropaoli, D., Russomando, U., Evangelista, P., & Ferri, C. (2018) · Public Health · doi:10.1016/j.puhe.2018.03.011 · Cited by 20
Yoo, I. Y., Lee, J., Choi, A., Jun, Y. H., Lee, H. Y., Kang, J. Y., & Park, Y.-J. (2021) · Diagnostics · doi:10.3390/diagnostics11091659 · Cited by 20
“The guidelines also recommend retesting low-risk individuals with an initial positive IGRA result, with a negative result in the retest overriding the initial positive result [16].”
Diagnostic value of tNGS vs Xpert MTB/RIF in childhood TB
Zheng, H., Yang, H., Wang, Y., Li, F.-N., Xiao, J., Guo, Y., Chen, H., Wang, X., Li, H., & Shen, C. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23217 · Cited by 20
Robison, H. M., Escalante, P., Valera, E., Erskine, C. L., Auvil, L. S., Sasieta, H. C., Bushell, C., Welge, M. E., & Bailey, R. C. (2019) · Integrative Biology · doi:10.1093/intbio/zyz001 · Cited by 25
Management of Advanced HIV Disease
Summers, N. A., & Armstrong, W. S. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2019.05.005 · Cited by 22
Kim, J. H., Kim, M. J., & Ham, S. (2019) · Medicine · doi:10.1097/md.0000000000016921 · Cited by 20
“Prompt diagnosis of pulmonary TB (PTB) is critical for appropriate therapeutic intervention and infection control.([4]) For the diagnosis of PTB, smear microscopy, and culture of the respiratory specimen (sputum or bronchial fluid) have been”
BackgroundThe latent tuberculosis infection cascade of care in Iqaluit, Nunavut, 2012–2016
Pease, C., Zwerling, A. A., Mallick, R., Patterson, M., Demaio, P., Finn, S., Allen, J., Dyk, D. V., & Alvarez, G. G. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4557-3 · Cited by 20
“However, this strategy is recommended for some low risk patients in American guidelines [25] and a recent trial found it to be noninferior to TST alone [26], suggesting that it may be reasonable in some cases.”
BackgroundPerformance of an Advanced Interferon-Gamma Release Assay forMycobacterium tuberculosisDetection
Altawallbeh, G., Gabrielson, D., Peters, J. M., & Killeen, A. A. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab012 · Cited by 20
Elbehiry, A., Marzouk, E., Edrees, H. M., AlShaqi, R., Ellethy, A. T., Alzaben, F. A., Anagreyyah, S. A., Algarni, A., Almuhaydili, K., AlOtaibi, I. A. B., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1596579 · Cited by 35
Aktualisierte S3-Leitlinie Colitis ulcerosa
Kucharzik, T. F., Dignass, A. U., Atreya, R. N., Bokemeyer, B., Esters, P., Herrlinger, K. R., Kannengießer, K., Kienle, P., Langhorst, J., Lügering, A., et al. (2019) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1015-7265 · Cited by 33
Concomitant Pulmonary Tuberculosis and Invasive Aspergillosis Infection in an Immunocompetent Host
Ahmed, A. O. E., Ali, G. A. M., & Goravey, W. (2022) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2022_003249 · Cited by 26
“Subsequently, BAL TB samples confirmed the diagnosis ([6]).”
BackgroundPeghin, M., Rodríguez-Pardo, D., Sánchez‐Montalvá, A., Pellisé, F., Rivas, A., Tórtola, T., Juan Aguilar‐Company, Almirante, B., & Pigrau, C. (2017) · Epidemiology and Infection · doi:10.1017/s0950268817000863 · Cited by 19
Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in California
Menzies, N. A., Parriott, A. M., Shrestha, S., Dowdy, D. W., Cohen, T., Salomon, J. A., Marks, S. M., Hill, A. N., Winston, C. A., Asay, G. R. B., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201907-1289oc · Cited by 19
Zeng, Q., Zhang, Y., Wu, Y., Zhang, Z., Zhang, J., Fu, H., Wang, J., Wang, F., Yan, C., Mo, X., et al. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.02.018 · Cited by 21
Bourlon, C., Camacho-Hernández, R., Fierro-Angulo, O. M., Acosta‐Medina, A. A., Bourlon, M. T., Niembro-Ortega, M. D., González-Lara, M. F., Sifuentes‐Osornio, J., & Ponce‐de‐León, A. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.03.013 · Cited by 19
Parriott, A. M., Malekinejad, M., Miller, A. P., Marks, S. M., Horváth, H., & Kahn, J. G. (2018) · BMC Public Health · doi:10.1186/s12889-018-5393-x · Cited by 18
“IGRA for testing [42], and the studies that did use IGRA re-”
MethodHirama, T., Sabur, N. F., Derkach, P., McNamee, J., Song, H. K., Marras, T. K., & Brode, S. K. (2020) · Canada Communicable Disease Report · doi:10.14745/ccdr.v46i04a05 · Cited by 18
“In our evaluation of the 2017 ATS/IDSA/CDC recommendations for rapid molecular DST for rifampin, we found that patients with MDR/RMP resistance were significantly more likely to have had previous TB treatment (OR 5.39, 95% CI 2.57–11.3) and HIV infection (OR 4.26, 95% CI 1.06–17.0) than DS-TB patients in multivariable…”
BackgroundMethodInfluentialHashash, J. G., Fadel, C. G. A., Hosni, M. N., Hassoun, L., Kanafani, Z. A., & Regueiro, M. D. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa139 · Cited by 18
Liu, H., Zhu, T., Li, Q., Xiong, X., Wang, J., Zhu, X., Zhou, X., Zhang, L., Zhu, Y., Peng, Y., et al. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104456 · Cited by 18
Self, J. L., McDaniel, C. J., Morris, S. B., & Silk, B. J. (2021) · Medical Care · doi:10.1097/mlr.0000000000001466 · Cited by 18
Sharif, N., Ahmed, D., Mahmood, R. T., Qasim, Z., Khan, S. N., Jabbar, A., Khattak, A. A., Asad, M. J., Ahmed, W., Khan, M. M., et al. (2021) · Brazilian Journal of Biology · doi:10.1590/1519-6984.244311 · Cited by 21
“2014; Penz et al., 2015; Ligthelm et al., 2011), while it is almost same to a study (Sarfaraz et al., 2018).”
BackgroundTesting for SARS-CoV-2: lessons learned and current use cases
Theel, E. S., Kirby, J. E., & Pollock, N. R. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00072-23 · Cited by 21
“…responses for infectious diseases is not a common diagnostic approach, aside from its current role for detection of latent tuberculosis infections or in the future, possibly for detection of re-established immunity to CMV following solid organ or hematopoietic stem cell transplantation (255, 256).”
Luo, L., Zhu, L., Yue, J., Liu, J., Liu, G., Zhang, X., Wang, H., & Xu, Y. (2017) · Emerging Microbes & Infections · doi:10.1038/emi.2017.54 · Cited by 18
Parmer, J., Allen, L., & Walton, W. (2017) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000521946.45448.90 · Cited by 18
“24, 25 These advantages make IGRAs the preferred test for people (including children five years old and older) who have received BCG vaccination, and also for those unlikely to return for a TST reading.(23) A posi-”
InfluentialVinuesa, V., Borrás, R., Briones, M. L., Clari, M. Á., Cresencio, V., Giménez, E., Muñoz, C., Oltra, R., Servera, E., Carabelli, T. S., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00116-18 · Cited by 19
“clinical practice guidelines for TB diagnosis in adults and children endorse the use of NAAT, albeit conditionally and based on low-quality evidence (8); uncertainties regarding field test performances and practical clinical utility have been invoked as accounting for this fact (6, 7).”
BackgroundMartín-Sánchez, M., Brugueras, S., de Andrés, A., Simón, P., Gorrindo, P., Ros, M., Masdeu, E., Millet, J.-P., Caylà, J. A., Orcau, À., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215322 · Cited by 18
“This allows us to detect any conversions in LTBI tests; conversions were defined as a change from a negative to a positive value in the TST or IGRA, according to the thresholds defined above[19].”
BackgroundMethodJiménez-Zarazúa, O., Vélez-Ramírez, L. N., Alcocer-León, M., Utrilla-Álvarez, J. D., Martínez-Rivera, M. A., Flores-Saldaña, G. A., & Mondragón, J. D. (2019) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2019.100105 · Cited by 19
“Other clinical findings associated with pulmonary TB are weight-loss, hemoptysis, and nocturnal diaphoresis [18,19].”
Ishida, E., Corrigan, D. T., Malonis, R. J., Hofmann, D., Chen, T., Amin, A. G., Chatterjee, D., Joe, M., Lowary, T. L., Lai, J. R., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02714-w · Cited by 20
Current Medical Management of Pulmonary Tuberculosis
Belknap, R. (2018) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2018.09.004 · Cited by 20
“AFB smears and cultures from pleural fluid generally detect less than 50% of active TB.(12) Pleural biopsy with tissue sent for pathology and cultures is the best method for definitively diagnosing pleural TB.”
BackgroundMethodInfluentialValidation of cellular tests for Lyme borreliosis (VICTORY) study
van de Schoor, F. R., Baarsma, M. E., Gauw, S. A., Joosten, L. A. B., Kullberg, B. J., van den Wijngaard, C. C., & Hovius, J. W. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4323-6 · Cited by 18
Wilson, J. W., Nilsen, D. M., & Marks, S. M. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201902-185cme · Cited by 17
“The higher prevalence of drugresistant TB among patients with HIV, especially among those who have lived within endemic TB regions, coupled with the increased risk of death if effective MDR TB treatment is delayed, further support the CDC recommendation for the routine adjunctive use of nucleic acid amplification test…”
Thomas, Κ., Hadziyannis, E. S., Hatzara, C., Makris, A., Tsalapaki, C., Lazarini, A., Klavdianou, K., Antonatou, K., Koutsianas, C., & Vassilopoulos, D. (2020) · Pathogens and Immunity · doi:10.20411/pai.v5i1.349 · Cited by 17
“Based on findings from several studies, recent guidelines recommend their use rather than TST as the diagnostic test of choice for individuals 5 years or older [6].”
MethodQuantiFERON-TB Gold Plus Performance in Children: A Narrative Review
Buonsenso, D., Seddon, J. A., Esposito, S., & Barcellini, L. (2023) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003877 · Cited by 18
“Pediatric TB remains neglected for various reasons, including difficulty diagnosing pulmonary TB and the belief that children do not contribute significantly to transmission.33 Given the incidence of pediatric TB1 and the high risk of progression and severe disease in young children,4 there is an urgent need to better…”
InfluentialImaging of musculoskeletal tuberculosis
Pattamapaspong, N., Kanthawang, T., Bouaziz, M. C., Ladeb, M. F., Hammami, N., & Peh, W. (2023) · British Journal of Radiology · doi:10.1093/bjr/tqad019 · Cited by 17
Nguyen, D. T., Phan, H., Trinh, T., Nguyen, H. N., Doan, H., Pham, N., Nguyen, H. V., Nguyen, H., Nguyen, H. V., Le, H. V., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213304 · Cited by 18
Tuberculosis mortality and associated factors at King Abdulaziz Medical City Hospital
Aljadani, R. H., Ahmed, A. E., & Al-Jahdali, H. H. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4063-7 · Cited by 17
Jiao, L., Song, J., Liu, D., Liu, T., Wu, T., Zhang, J., Bai, H., Chen, H., Zhao, Z., & Ying, B. (2019) · DNA and Cell Biology · doi:10.1089/dna.2019.5082 · Cited by 17
Treatment of Bone and Joint Tuberculosis in France: A Multicentre Retrospective Study
Guillouzouic, A., Andréjak, C., Peuchant, O., Héry-Arnaud, G., Hamdad, F., Lanotte, P., Gaborit, B. J., Bernard, L., & Bémer, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082529 · Cited by 17
Latent tuberculosis testing through the ages: the search for a sleeping killer
Kestler, B., & Tyler, S. K. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00217.2021 · Cited by 17
Kang, Y. A., Koo, B., Kim, O., Park, J. H., Kim, H. C., Lee, H. J., Kim, M. G., Jang, Y., Kim, N. H., Koo, Y. S., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00207-22 · Cited by 17
“The suspicion of PTB was based on the participants’ symptoms, history, and radiographic findings suggestive of TB (33, 34), and the enrollment was decided by three respiratory and infection specialists (SHK, YAK, and SWL) who each had experience in TB treatment for more than 15 years.”
MethodAlrajhi, S., Germain, P., Martel, M., Lakatos, P. L., Bessissow, T., Al-Taweel, T., & Afif, W. (2020) · Intestinal Research · doi:10.5217/ir.2019.00116 · Cited by 18
Fernandez‐Blázquez, A., Menéndez, P. A., Sabater-Cabrera, C., García-García, J.-M., Asensi, V., & Palacios, J. J. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2020.04.011 · Cited by 16
Li, Z., Hu, J., Liu, P.-C., Cui, D., Di, H., & Wu, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-93893-3 · Cited by 16
Pneumonia in the Immunocompromised Host
Murali, S., Marks, A., Heeger, A. P., Dako, F., & Febbo, J. (2021) · Seminars in Roentgenology · doi:10.1053/j.ro.2021.10.009 · Cited by 16
Deciphering a TB-related DNA methylation biomarker and constructing a TB diagnostic classifier
Lyu, M., Zhou, J., Jiao, L., Wang, Y., Zhou, Y., Lai, H., Xu, W., & Ying, B. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.11.014 · Cited by 15
“For example, incipient TB is characterized by an indeterminate period of asymptomatic infection or absence of typical clinical symptoms and imaging features, which limit the effectiveness of TB diagnosis.(6) Therefore, new and more powerful detection tools are urgently needed.”
BackgroundKim, H. W., Kim, K. H., Shin, A. Y., Choi, J. Y., Ahn, J. H., Kim, J. S., Ban, W. H., Oh, J., & Ha, J. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-11460-w · Cited by 16
Marks, S. M., Self, J. L., Venkatappa, T. K., Wolff, M. B., Hopkins, P. B., Augustine, R. J., Khan, A., Schwartz, N. G., Schmit, K. M., & Morris, S. B. (2023) · Public Health Reports · doi:10.1177/00333549221148173 · Cited by 16
“9,20 Although homelessness has been associated with non-completion of LTBI treatment, the use of short rifamycin-based 3-or 4-month regimens compared with 6-or 9-month isoniazid-monotherapy regimens can facilitate successful completion of LTBI treatment, including among PEH, 54-57 as does LTBI…”
Menzies, N. A., Swartwood, N. A., Cohen, T., Marks, S. M., Maloney, S. A., Chappelle, C., Miller, J. W., Asay, G. R. B., Date, A. A., Horsburgh, C. R., et al. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00150-6 · Cited by 18
“…incidence and other populations with elevated M tuberculosis infection prevalence or medical risk factors for rapid disease progression), 14,15 rapid detection of new tuberculosis cases and contact investigation to interrupt transmission, strengthening care cascades for individuals with M…”
Wu, X., Wang, Y., Weng, T.-H., Hu, C. W., Wang, F. X. C., Wu, Z., Yu, D.-S., Lu, H., & Yao, H. (2017) · Medicine · doi:10.1097/md.0000000000009350 · Cited by 21
Adenosine Deaminase Diagnostic Testing in Pericardial Fluid
Chau, E., Sarkarati, M., & Spellberg, B. J. (2019) · JAMA · doi:10.1001/jama.2019.7535 · Cited by 16
Prevalence of latent tuberculosis infection in Syrian refugees to Canada
Warrington, P., Tyrrell, G. J., Choy, K., Eisenbeis, L., Long, R., & Cooper, R. D. (2018) · Canadian Journal of Public Health · doi:10.17269/s41997-018-0028-7 · Cited by 16
“IGRA has a greater specificity than TST (tuberculin skin test) in populations with high BCG vaccinations such as Syria, and recent consensus guidelines suggest this is the standard of care in this population (World Health Organization 2016c; Lewinsohn et al. 2017).”
BackgroundA case of disseminated tuberculosis mimicking metastatic cancer
Chamberlin, K., Orfanos, S., Mukherjee, A., Moy, E. K.-L., Koganti, M., & Khan, W. (2018) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2018.10.001 · Cited by 16
Diagnosing Viral Infections Through T-Cell Receptor Sequencing of Activated CD8+ T Cells
Vujkovic, A., Ha, M. K., de Block, T., van Petersen, L., Brosius, I., Theunissen, C., van Ierssel, S. H., Bartholomeus, E., Adriaensen, W. J., Vanham, G. L., et al. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad430 · Cited by 15
“In the control of Mycobacterium tuberculosis (TB), the identification of both patients with active disease and latent TB infection is important [25].”
BackgroundImpact of diabetes itself and glycemic control status on tuberculosis
Meng, F., Lan, L., Wu, G., Ren, X., Yuan, X., Yang, M., Chen, Q., Peng, X., & Liu, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1250001 · Cited by 20
Zhao, T., Zhang, J., Zhang, X., & Wang, C. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03055-0 · Cited by 15
A framework for exclusion of alternative diagnoses in sarcoidosis
Harper, L. J., Farver, C. F., Yadav, R., & Culver, D. A. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103288 · Cited by 16
Diefenbach-Elstob, T. R., Alabdulkarim, B., Deb‐Rinker, P., Pernica, J. M., Schwarzer, G., Menzies, D., Shrier, I., Schwartzman, K., & Greenaway, C. A. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa214 · Cited by 15
“Furthermore, the highest risk of progression from LTBI to active TB is in the first 2 years following MTB exposure.(44) Therefore, for studies with relatively short follow-up times it is possible that additional cases of active TB developed post-travel, but were missed because they occurred after the follow-up period.”
BackgroundTuberculosis in the paediatric age group: a reflection on transmission
Silva, J. B., Santos, J. C., Barbosa, L., & Carvalho, I. (2020) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2020.12.002 · Cited by 15
Thitisuriyarax, S., Vanichanan, J., Udomkarnjananun, S., Townamchai, N., & Jutivorakool, K. (2021) · Transplant Infectious Disease · doi:10.1111/tid.13566 · Cited by 15
“Duration of TB developed after transplant- median month (IQR) 17 (4-59)”
BackgroundPrevention of Mycobacterium tuberculosis Transmission in Health Care Settings
Swaminathan, N., Perloff, S. R., & Zuckerman, J. M. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.07.003 · Cited by 15
Jiang, J., Cao, Z., Li, X., Su, J., Wang, J., Liang, J., Yang, B., Liu, Y., Zhai, F., Wang, R., et al. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109266 · Cited by 15
Shin, H., Kim, T.-O., Oh, H., Park, H.-Y., Chang, J., Ahn, S., Kim, Y., Lim, S., & Kwon, Y. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181887 · Cited by 15
Vajravelu, R. K., Osterman, M. T., Aberra, F. N., Roy, J. A., Lichtenstein, G. R., Mamtani, R., Goldberg, D. S., Lewis, J. D., & Scott, F. I. (2017) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx019 · Cited by 15
Herce, M. E., Muyoyeta, M., Topp, S. M., Henostroza, G., & Reid, S. E. (2018) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000505 · Cited by 20
A new DNA sensor system for specific and quantitative detection of mycobacteria
Franch, O., Xiao, H., Marcussen, L. B., Jørgensen, A. G., Andersen, M. B., Godbole, A. A., Harmsen, C., Nørskov‐Lauritsen, N., Thomsen, J., Pedersen, F. S., et al. (2018) · Nanoscale · doi:10.1039/c8nr07850e · Cited by 15
Shaw, J., Ahmed, L., & Koegelenberg, C. F. N. (2020) · European Respiratory Society eBooks · doi:10.1183/2312508x.10023819 · Cited by 17
Horne, D. J. D. L., Zifodya, J. S., Shapiro, A. E., Church, E. C., Kreniske, J. S., Kay, A. W., Scandrett, K., Steingart, K. R., & Takwoingi, Y. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub6 · Cited by 36
Cocrystals of Isoniazid with Polyphenols: Mechanochemical Synthesis and Molecular Structure
González-González, J. S., Martínez-Santiago, A. M. M., Martı́nez-Martı́nez, F. J., Emparán-Legaspi, M. J., Pineda‐Contreras, A., Flores-Álamo, M., & García-Ortega, H. (2020) · Crystals · doi:10.3390/cryst10070569 · Cited by 14
Martínez-Domínguez, J., Sierra-Martínez, O., Galindo‐Fraga, A., Trejo-Mejía, J. A., Mendiola, M. S., Ochoa‐Hein, E., Vázquez-Rivera, M., Gutiérrez‐Cirlos, C., Naveja, J., & Martínez-González, A. (2022) · BMC Medical Education · doi:10.1186/s12909-022-03499-0 · Cited by 19
Infectious Disease Prophylaxis During and After Immunosuppressive Therapy
Schweitzer, L., Miko, B. A., & Pereira, M. R. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.04.043 · Cited by 15
Pennington, K. M., Kennedy, C. C., Chandra, S., Lauzardo, M., Brito, M. O., Griffith, D. E., Seaworth, B. J., & Escalante, P. (2018) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2018.04.001 · Cited by 14
“After reviewing the recently released American Thoracic Society(ATS), Centers for Disease Control and Prevention(CDC), and Infectious Disease Society of America(IDSA) diagnostic and treatment guidelines, we decided to publish this original work and discuss our findings in comparison with the most recent published data…”
BackgroundResultTuberculosis Screening, Testing, and Treatment of US Health Care Personnel
Thanassi, W. T., Behrman, A. J., Reves, R. R., Russi, M. B., Swift, M. D., Warkentin, J. V., Miyakawa, R., Wegener, D. H., Budnick, L. D., Murray, E., et al. (2020) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001904 · Cited by 14
“For TSPOT, a negative result is returned when the number of spots counted (range 0 to 100s) is 0 to 4 in the US and 0 to 6 in Europe, equating to a 95% to 97% specificity.(14,26)”
BackgroundInfluentialLiu, L., Deng, J., Yang, Q., Wei, C., Liu, B., Zhang, H., Xin, H., Pan, S., Liu, Z., Wang, D., et al. (2021) · IUBMB Life · doi:10.1002/iub.2509 · Cited by 14
Chitnis, A. S., Cheung, R. C., Gish, R. G., & Wong, R. J. (2021) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-021-01231-6 · Cited by 15
“There are two sets of guidelines for LTBI diagnosis [75, 76], and one guideline for LTBI treatment [77].”
BackgroundInfluentialStockbridge, E. L., Miller, T. L., Carlson, E., & Ho, C. S. (2018) · BMC Public Health · doi:10.1186/s12889-018-5578-3 · Cited by 16
“This is consistent with the CDC guidelines [40] and suggests that Fig.”
Nam, S. H., Oh, J. S., Hong, S., Shim, T. S., Lee, C., Yoo, B., & Kim, Y. (2020) · Joint Bone Spine · doi:10.1016/j.jbspin.2020.04.010 · Cited by 14
Cao, H., Huan, C., Wang, Q., Xu, G., Lin, J., & Zhou, J. (2020) · Rheumatology and Therapy · doi:10.1007/s40744-020-00244-1 · Cited by 15
Mishra, S., & Saito, K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1029111 · Cited by 15
“To maximize yield, current CDC guidelines recommend three sputum smears for assessment of AFB by microscopy as well as sending all collected sputum for mycobacterial culture (Lewinsohn et al., 2017).”
BackgroundMethodInfluentialUrabe, N., Sakamoto, S., Masuoka, M., Kato, C., Yamaguchi, A., Tokita, N., Homma, S. A., & Kishi, K. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02327-5 · Cited by 13
“Abbreviations AFB Acid-fast bacilli ATS American Thoracic Society BMI Body mass index COPD Chronic Obstructive Pulmonary Disease CAT Chronic Obstructive Pulmonary Disease assessment testing CT Computed tomography CI Confidence interval ERS European Respiratory Society ESCMID European Society of Clinical Microbiology G…”
InfluentialHIV/Tuberculosis Coinfection in Pregnancy and the Postpartum Period
Yilma, A., Bailey, H., Karakousis, P. C., & Karanika, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196302 · Cited by 14
Huang, F., Wang, H., Qiao, R., Peng, Q., Zhao, C., & Miao, L. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1243441 · Cited by 17
Qin, W., Guo, T., You, T., Tian, R., Cui, X., & Wang, P. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116402 · Cited by 15
Jiang, J., Cao, Z., Li, B., Ma, X., Deng, X., Yang, B., Liu, Y., Zhai, F., & Cheng, X. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106231 · Cited by 13
Silicotuberculosis: a critical narrative review
Ehrlich, R. I., Murray, J., Said-Hartley, Q., & Rees, D. (2024) · European Respiratory Review · doi:10.1183/16000617.0168-2024 · Cited by 18
Ravnholt, C., Qvist, T., Kolpen, M., Pressler, T., Skov, M., & Høiby, N. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.11.011 · Cited by 13
Diagnosis and Treatment of Latent Tuberculosis Infection: The Updated 2017 Korean Guidelines
Lee, S. H. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.6.509 · Cited by 13
“미국은 IGRA 또는 TST를 사용 할 수 있다고 권고하되, 최근 지침에서는 IGRA를 우선 권고 하고 있고[4], 영국은 TST를 기본으로 하되 상황에 따라 IGRA 단독 또는 추가 검사를 하도록 권고하고 있다[5].”
Urinary tuberculosis: still a challenge
Mert, A., Güzelburç, V., & Güven, S. (2020) · World Journal of Urology · doi:10.1007/s00345-020-03146-7 · Cited by 13
“Culture, although the diagnostic gold standard, has a sensitivity of 80%--90% and the results may take 6–8 weeks to be released [10, 14, 15, 16, 20, 23].”
BackgroundInterferon-Gamma Release Assay Testing in Children Younger Than 2 Years in a US-Based Health System
Gaensbauer, J. T., Young, J., Harasaki, C., Aiona, K., Belknap, R., & Haas, M. K. (2020) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002711 · Cited by 13
“In many clinical scenarios and age groups, the interferon-gamma release assays (IGRAs) have replaced TST.(6) IGRAs require a single visit and rely on standard laboratory technical skills.”
InfluentialPettit, A. C., Stout, J. E., Belknap, R., Benson, C. A., Séraphin, M. N., Lauzardo, M., Horne, D. J. D. L., Garfein, R. S., Maruri, F., Ho, C. S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1135 · Cited by 13
Self-citation(2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6824a4 · Cited by 13
“When findings, such as chest radiography and mycobacterial cultures, are sufficient for confirming or excluding the TB diagnosis, the results from a TST or an IGRA blood test might not be needed (1).”
InfluentialYu, Q., Yan, J., Tian, S., Weng, W., Luo, H., Wei, G., Long, G., Ma, J., Gong, F., & Wang, X. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.947954 · Cited by 13
Singh, K., Hyatali, S., Giddings, S., Singh, K. N., & Bhagwandass, N. (2017) · Case Reports in Critical Care · doi:10.1155/2017/9287021 · Cited by 13
“Mycobacterial culture can take up to a month to be available, while molecular techniques, as was done in this case, can give a result in hours and is recommended by consensus guidelines [15, 16].”
Aspiration: /aspə’rāSH(ə)n/: Noun: An Ambiguous Term Used for a Diagnosis of Uncertainty
Ferguson, J., Ravert, B., & Michael, G. (2018) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000277 · Cited by 14
Islam, M. S., Chughtai, A. A., Nazneen, A., Chowdhury, K. I. A., Islam, M. T., Tarannum, S., Islam, S. M. H., Banu, S., & Seale, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243951 · Cited by 14
Ye, Y., Yang, N., Zhou, J., Qian, G., & Chu, J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.687984 · Cited by 13
Metadata
- Authors
- Lewinsohn, D. M., Leonard, M. K., LoBue, P. A., Cohn, D. L., Daley, C. L., Desmond, E., Keane, J., Lewinsohn, D. A., Loeffler, A. M., Mazurek, G. H., O’Brien, R. J., Pai, M., Richeldi, L., Salfinger, M., Shinnick, T. M., Sterling, T. R., Warshauer, D. M., & Woods, G. L.
- Affiliations
- Oregon Health & Science University (US)
- Emory University School of Medicine and
- Centers for Disease Control and Prevention (US)
- Denver Public Health (US)
- National Jewish Health (US)
- California Department of Public Health (US)
- St. James's Hospital (IE)
- Francis J. Curry International TB Center, San Francisco, California;
- FIND (CH)
- McGill University (CA)
- University of Southampton (GB)
- Vanderbilt University (US)
- Wisconsin State Laboratory of Hygiene, Madison, and
- University of Arkansas for Medical Sciences (US)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-12-08
- Volume
- 64
- Issue
- 2
- Pages
- e1-e33
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5504475
- OpenAlex
- W2559832962
- Cited by
- 992
- References
- 246
- Citations by year
- 2026: 65 · 2025: 81 · 2024: 91 · 2023: 101 · 2022: 115 · 2021: 142 · 2020: 133 · 2019: 110 · 2018: 96 · 2017: 55 · 2016: 1
- FWCI
- 80.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- tuberculosis diagnosis, latent tuberculosis infection, pulmonary tuberculosis, extrapulmonary tuberculosis, Mycobacterium tuberculosis, diagnostic testing, children, adults
- MeSH terms
- Adult, Age Factors, Child, Humans, Mycobacterium tuberculosis, Tuberculosis, Tuberculosis, Pulmonary, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.